The findings of our MR analysis, which we conducted after deleting these confounding factors SNPs, indicated a substantial causation estimate between higher ACE2 levels and a lower chance of developing lung cancer (odds ratio: 0.94, 95% confidence interval: 0.90–0.98, P = 0.0016). Here, ACE2 is linked to lung cancer.